All stock lists
Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
Healthcare · Biotechnology
$13.93-$4.10 (-22.74%)
Insider Score
––Not scored
YARW Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
YARW Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Jun 30, 2025 |
| Revenue | $97.00 K | $0.00 | $0.00 | $69.00 K |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| SG&A Expense | $2.41 M | $1.62 M | $390.00 K | $2.73 M |
| R&D Expense | $788.00 K | $1.25 M | $604.00 K | $4.88 M |
| Operating Expenses | $3.20 M | $2.86 M | $994.00 K | $7.61 M |
| Operating Income | -$3.10 M | -$2.86 M | -$994.00 K | -$7.54 M |
| Pretax Income | -$2.90 M | -$2.75 M | -$70.99 M | -$5.75 M |
| Tax Provision | $0.00 | — | — | $0.00 |
| Net Income | -$3.01 M | -$2.75 M | -$70.99 M | -$5.75 M |
| EPS (Basic) | -$175.50 | -$159.97 | -$4137.18 | -$336.50 |
| EPS (Diluted) | -$175.50 | -$159.97 | -$4137.18 | -$336.50 |
| Shares Outstanding | 17.16 K | 17.16 K | 17.16 K | 17.10 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
